Horizon Discovery: Capitalizing on CRISPR

With broad basic science and translational applications, gene editing technology is driving innovative life science and medical research around the world.

The Scientist Marketing Team
Feb 15, 2016

Genetic engineering has been boosted by the discovery and characterization of CRIPSR-associated Cas9 RNA-guided endonuclease. This technology enables the rapid manipulation of genes as well as genome-wide functional screening. With broad basic science and translational applications, this technology is driving innovative life science and medical research around the world. To learn more about how Horizon's gene editing technology is supporting and advancing translational genomics research and the development of personalized medicines, or for help with any gene editing applications, please visit horizondiscovery.com

Interested in reading more?

The Scientist ARCHIVES

Become a Member of

Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?